Danka Radosavljevic
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Danka Radosavljevic is currently Chief Operating Officer at Eton Pharmaceuticals, Inc. Formerly, Mr. Radosavljevic worked as a Project Manager at Akorn, Inc. and as a Quality Control & Analytical Development Scientist at Morton Grove Pharmaceuticals, Inc. Mr. Radosavljevic completed undergraduate studies at the University of Illinois.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/07/2026 | 22 473 ( 0,08% ) | 1 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Directeur des opérations | - |
| Sociétés | Poste | Fin |
|---|---|---|
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Corporate Officer/Principal | - |
| AKORN, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national